1. Home
  2. DLPN vs NXL Comparison

DLPN vs NXL Comparison

Compare DLPN & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.72

Market Cap

20.6M

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.51

Market Cap

18.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
NXL
Founded
1996
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.6M
18.6M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
DLPN
NXL
Price
$1.72
$0.51
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
41.2K
384.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
27.81
N/A
EPS
N/A
N/A
Revenue
$51,684,984.00
N/A
Revenue This Year
$10.62
$38.28
Revenue Next Year
$13.78
$185.71
P/E Ratio
N/A
N/A
Revenue Growth
19.85
N/A
52 Week Low
$0.75
$0.37
52 Week High
$1.88
$2.80

Technical Indicators

Market Signals
Indicator
DLPN
NXL
Relative Strength Index (RSI) 61.33 47.84
Support Level $1.46 $0.37
Resistance Level $1.73 $0.69
Average True Range (ATR) 0.09 0.07
MACD 0.02 0.01
Stochastic Oscillator 94.64 51.97

Price Performance

Historical Comparison
DLPN
NXL

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: